glp 1 taste in mouth GLP-1s, and what's happening to our diets #ADAICYMI: What is “Ozempic Tongue”?

GLP-1 and ROSE-010 suppress postprandial GI motility, most likely via GLP-1R at myenteric neurons, necessitating functioning cAMP and nitrergic signaling ( According to the current studys findings, ROSE-010 is linked to a greater incidence of headaches, nausea, and vomiting than placebo

Relevance for ED research: Is it better than subcutaneous

The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly

Alternative GLP-1 agent: Switching to a different GLP-1 receptor agonist with different pharmacokinetic properties may be beneficial, as individual patient responses vary